IR Biosciences Holdings Inc.
IRBS · OTC
12/31/2010 | 9/30/2010 | 6/30/2010 | 3/31/2010 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $1 | $1 |
| Operating Income | -$0 | -$0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$2 | $2 | -$2 |
| Pre-Tax Income | -$0 | -$3 | $1 | -$3 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$0 | -$3 | $1 | -$3 |
| % Margin | – | – | – | – |
| EPS | -0.02 | -0.17 | 0.08 | -0.24 |
| % Growth | 88% | -312.5% | 133.3% | – |
| EPS Diluted | -0.02 | -0.17 | 0.08 | -0.24 |
| Weighted Avg Shares Out | 17 | 17 | 15 | 14 |
| Weighted Avg Shares Out Dil | 17 | 17 | 15 | 14 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$3 | $2 | -$3 |
| % Margin | – | – | – | – |